XML 38 R27.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SHAREHOLDERS’ EQUITY (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Equity [Abstract] |
SCHEDULE OF RESTRICTED STOCK ACTIVITY | Below is a summary of restricted stock activity for the three months ended March 31, 2024: SCHEDULE OF RESTRICTED STOCK ACTIVITY
|  | For the Three Months Ended |
|  | March 31, 2024 |
|  |  |  |  | Weighted Average |
|  | Shares |  |  | Grant Date Fair Value |
Nonvested at beginning of period |  |  | 144,211 |  |  | $ | 34.07 |
Granted |  |  | 105,934 |  |  |  | 37.36 |
Vested |  |  | (51,656 | ) |  |  | 32.03 |
Forfeited |  |  | (5,272 | ) |  |  | 32.66 |
Nonvested at March 31, 2024 |  |  | 193,217 |  |  | $ | 36.46 |
SCHEDULE OF STOCK OPTION ACTIVITY | A summary of the status of outstanding stock options at March 31, 2024 and changes during the three months ended is presented below: SCHEDULE OF STOCK OPTION ACTIVITY
|  | For the Three Months Ended |  |  |  |
|  | March 31, 2024 |  |  |  |
|  |  |  |  | Weighted Average Exercise |  |  | Weighted Average Remaining |  |  | Aggregate Intrinsic |
|  | Options |  |  | Price |  |  | Contract Life |  |  | Value |
Outstanding at beginning of period |  |  | 93,892 |  |  | $ | 10.22 |  |  |  |  |  |  |  |  |
Granted or assumed |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Exercised |  |  | (3,059 | ) |  |  | 12.02 |  |  |  |  |  |  |  |  |
Forfeited |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Expired |  |  | - |  |  |  | - |  |  |  |  |  |  |  |  |
Outstanding at March 31, 2024 |  |  | 90,833 |  |  | $ | 10.16 |  |  |  | 6.6 |  |  | $ | 2,438,222.4 |
Exercisable at March 31, 2024 |  |  | 90,833 |  |  | $ | 10.16 |  |  |  | 6.6 |  |  | $ | 2,438,222.4 |
SCHEDULE OF WARRANTS TO PURCHASE COMMON STOCK | A summary of the status of outstanding warrants to purchase common stock at March 31, 2024 and changes during the three months then ended is presented below: SCHEDULE OF WARRANTS TO PURCHASE COMMON STOCK
|  | For the Three Months Ended |
|  | March 31, 2024 |
|  |  |  |  | Weighted Average |  |  | Weighted Average |
|  | Warrants |  |  | Exercise Price |  |  | Remaining Contract Life |
Outstanding at beginning of period |  |  | 16,725 |  |  | $ | 10.80 |  |  |  |  |
Granted or assumed |  |  | - |  |  |  | - |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Forfeited |  |  | - |  |  |  | - |  |  |  |  |
Expired |  |  | - |  |  |  | - |  |  |  |  |
Outstanding at March 31, 2024 |  |  | 16,725 |  |  | $ | 10.80 |  |  |  | 6.5 |
Exercisable at March 31, 2024 |  |  | 16,725 |  |  | $ | 10.80 |  |  |  | 6.5 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration